Abstract
Alternative splicing is an essential mechanism of gene regulation, giving rise to remarkable protein diversity in higher eukaryotes. Epithelial-mesenchymal transition (EMT) is a developmental process that plays an essential role in metazoan embryogenesis. Recent studies have revealed that alternative splicing serves as a fundamental layer of regulation that governs cells to undergo EMT. In this review, we summarize recent findings on the functional impact of alternative splicing in EMT and EMT-associated activities. We then discuss the regulatory mechanisms that control alternative splicing changes during EMT.
References
1.
Aceto
N
, Bardia
A
, Miyamoto
DT
, Donaldson
MC
, Wittner
BS
, Spencer
JA
, Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis
. Cell
. 2014
;158
:1110
–22
. .2.
Acloque
H
, Adams
MS
, Fishwick
K
, Bronner-Fraser
M
, Nieto
MA
. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease
. J Clin Invest
. 2009
;119
:1438
–49
. .3.
Ahuja
N
, Ashok
C
, Natua
S
, Pant
D
, Cherian
A
, Pandkar
MR
, Hypoxia-induced TGF-β-RBFOX2-ESRP1 axis regulates human MENA alternative splicing and promotes EMT in breast cancer
. NAR Cancer
. 2020
;2
:zcaa021
. .4.
Aiello
NM
, Brabletz
T
, Kang
Y
, Nieto
MA
, Weinberg
RA
, Stanger
BZ
. Upholding a role for EMT in pancreatic cancer metastasis
. Nature
. 2017
;547
:E7
–8
. .5.
Aiello
NM
, Kang
Y
. Context-dependent EMT programs in cancer metastasis
. J Exp Med
. 2019
;216
:1016
–26
. .6.
Aktas
B
, Tewes
M
, Fehm
T
, Hauch
S
, Kimmig
R
, Kasimir-Bauer
S
. Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
. Breast Cancer Res
. 2009
;11
:R46
. .7.
Applewhite
DA
, Barzik
M
, Kojima
S
, Svitkina
TM
, Gertler
FB
, Borisy
GG
. Ena/VASP proteins have an anti-capping independent function in filopodia formation
. Mol Biol Cell
. 2007
;18
:2579
–91
. .8.
Aruffo
A
, Stamenkovic
I
, Melnick
M
, Underhill
CB
, Seed
B
. CD44 is the principal cell surface receptor for hyaluronate
. Cell
. 1990
;61
:1303
–13
. .9.
Baralle
FE
, Giudice
J
. Alternative splicing as a regulator of development and tissue identity
. Nat Rev Mol Cell Biol
. 2017
;18
:437
–51
. .10.
Barrett
SP
, Salzman
J
. Circular RNAs: analysis, expression and potential functions
. Development
. 2016
;143
:1838
–47
. .11.
Barzik
M
, Kotova
TI
, Higgs
HN
, Hazelwood
L
, Hanein
D
, Gertler
FB
, Ena/VASP proteins enhance actin polymerization in the presence of barbed end capping proteins
. J Biol Chem
. 2005
;280
:28653
–62
. .12.
Bebee
TW
, Park
JW
, Sheridan
KI
, Warzecha
CC
, Cieply
BW
, Rohacek
AM
, The splicing regulators Esrp1 and Esrp2 direct an epithelial splicing program essential for mammalian development
. eLife
. 2015
;4
:e08954
. .13.
Bennett
KL
, Jackson
DG
, Simon
JC
, Tanczos
E
, Peach
R
, Modrell
B
, CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor
. J Cell Biol
. 1995
;128
:687
–98
. .14.
Bhattacharya
R
, Mitra
T
, Ray Chaudhuri
S
, Roy
SS
. Mesenchymal splice isoform of CD44 (CD44s) promotes EMT/invasion and imparts stem-like properties to ovarian cancer cells
. J Cell Biochem
. 2018
;119
:3373
–83
. .15.
Biamonti
G
, Bonomi
S
, Gallo
S
, Ghigna
C
. Making alternative splicing decisions during epithelial-to-mesenchymal transition (EMT)
. Cell Mol Life Sci
. 2012
;69
:2515
–26
. .16.
Bonomi
S
, di Matteo
A
, Buratti
E
, Cabianca
DS
, Baralle
FE
, Ghigna
C
, HnRNP A1 controls a splicing regulatory circuit promoting mesenchymal-to-epithelial transition
. Nucleic Acids Res
. 2013
;41
:8665
–79
. .17.
Brabletz
T
, Kalluri
R
, Nieto
MA
, Weinberg
RA
. EMT in cancer
. Nat Rev Cancer
. 2018
;18
:128
–34
. .18.
Braeutigam
C
, Rago
L
, Rolke
A
, Waldmeier
L
, Christofori
G
, Winter
J
. The RNA-binding protein Rbfox2: an essential regulator of EMT-driven alternative splicing and a mediator of cellular invasion
. Oncogene
. 2014
;33
:1082
–92
. .19.
Brown
RL
, Reinke
LM
, Damerow
MS
, Perez
D
, Chodosh
LA
, Yang
J
, CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression
. J Clin Invest
. 2011
;121
:1064
–74
. .20.
Camp
ER
, Liu
W
, Fan
F
, Yang
A
, Somcio
R
, Ellis
LM
, RON, a tyrosine kinase receptor involved in tumor progression and metastasis
. Ann Surg Oncol
. 2005
;12
:273
–81
. .21.
Carroll
SH
, Macias Trevino
C
, Li
EB
, Kawasaki
K
, Myers
N
, Hallett
SA
, An Irf6-Esrp1/2 regulatory axis controls midface morphogenesis in vertebrates
. Development
. 2020
;147
:dev194498. .22.
Chaffer
CL
, San Juan
BP
, Lim
E
, Weinberg
RA
. EMT, cell plasticity and metastasis
. Cancer Metastasis Rev
. 2016
;35
:645
–54
. .23.
Chaffer
CL
, Thompson
EW
, Williams
ED
. Mesenchymal to epithelial transition in development and disease
. Cells Tissues Organs
. 2007
;185
:7
–19
. .24.
Chaffer
CL
, Weinberg
RA
. A perspective on cancer cell metastasis
. Science
. 2011
;331
:1559
–64
. .25.
Chao
YL
, Shepard
CR
, Wells
A
. Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition
. Mol Cancer
. 2010
;9
:179
. .26.
Cheng
C
, Yaffe
MB
, Sharp
PA
. A positive feedback loop couples Ras activation and CD44 alternative splicing
. Genes Dev
. 2006
;20
:1715
–20
. .27.
Conn
SJ
, Pillman
KA
, Toubia
J
, Conn
VM
, Salmanidis
M
, Phillips
CA
, The RNA binding protein quaking regulates formation of circRNAs
. Cell
. 2015
;160
:1125
–34
. .28.
Culty
M
, Miyake
K
, Kincade
PW
, Sikorski
E
, Butcher
EC
, Underhill
C
, The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins
. J Cell Biol
. 1990
;111
:2765
–74
. .29.
Dhamija
S
, Diederichs
S
. From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis
. Int J Cancer
. 2016
;139
:269
–80
. .30.
Dittmar
KA
, Jiang
P
, Park
JW
, Amirikian
K
, Wan
J
, Shen
S
, Genome-wide determination of a broad ESRP-regulated posttranscriptional network by high-throughput sequencing
. Mol Cell Biol
. 2012
;32
:1468
–82
. .31.
Dongre
A
, Weinberg
RA
. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer
. Nat Rev Mol Cell Biol
. 2019
;20
:69
–84
. .32.
Faux
MC
, King
LE
, Kane
SR
, Love
C
, Sieber
OM
, Burgess
AW
. APC regulation of ESRP1 and p120-catenin isoforms in colorectal cancer cells
. Mol Biol Cell
. 2021
;32
(2
):120
–30
. .33.
Fischer
KR
, Durrans
A
, Lee
S
, Sheng
J
, Li
F
, Wong
ST
, Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
. Nature
. 2015
;527
:472
–6
. .34.
Fu
X-D, Ares M
Jr. Context-dependent control of alternative splicing by RNA-binding proteins
. Nature Reviews Genetics
. 2014
;15
:689
–701
.35.
Gertler
FB
, Niebuhr
K
, Reinhard
M
, Wehland
J
, Soriano
P
. Mena, a relative of VASP and Drosophila Enabled, is implicated in the control of microfilament dynamics
. Cell
. 1996
;87
:227
–39
. .36.
Ghigna
C
, Giordano
S
, Shen
H
, Benvenuto
F
, Castiglioni
F
, Comoglio
PM
, Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene
. Mol Cell
. 2005
;20
:881
–90
. .37.
Goel
HL
, Gritsko
T
, Pursell
B
, Chang
C
, Shultz
LD
, Greiner
DL
, Regulated splicing of the α6 integrin cytoplasmic domain determines the fate of breast cancer stem cells
. Cell Rep
. 2014
;7
:747
–61
. .38.
Gonçalves
V
, Matos
P
, Jordan
P
. Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways
. Hum Mol Genet
. 2009
;18
:3696
–707
. .39.
Gordon
MA
, Babbs
B
, Cochrane
DR
, Bitler
BG
, Richer
JK
. The long non-coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2-mediated alternative splicing
. Mol Carcinog
. 2019
;58
:196
–205
. .40.
Grelet
S
, Link
LA
, Howley
B
, Obellianne
C
, Palanisamy
V
, Gangaraju
VK
, A regulated PNUTS mRNA to lncRNA splice switch mediates EMT and tumour progression
. Nat Cell Biol
. 2017
;19
:1105
–15
. .41.
Gugnoni
M
, Ciarrocchi
A
. Long noncoding RNA and epithelial mesenchymal transition in cancer
. Int J Mol Sci
. 2019
;20
(8
):1924
. .42.
Han
SP
, Tang
YH
, Smith
R
. Functional diversity of the hnRNPs: past, present and perspectives
. Biochem J
. 2010
;430
:379
–92
. .43.
Harvey
SE
, Xu
Y
, Lin
X
, Gao
XD
, Qiu
Y
, Ahn
J
, Coregulation of alternative splicing by hnRNPM and ESRP1 during EMT
. RNA
. 2018
;24
:1326
–38
. .44.
Hiraga
T
, Ito
S
, Nakamura
H
. Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production
. Cancer Res
. 2013
;73
:4112
–22
. .45.
Hopkins
A
, Coatham
ML
, Berry
FB
. FOXC1 regulates FGFR1 isoform switching to promote invasion following TGFβ-induced EMT
. Mol Cancer Res
. 2017
;15
:1341
–53
. .46.
Horiguchi
K
, Sakamoto
K
, Koinuma
D
, Semba
K
, Inoue
A
, Inoue
S
, TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP
. Oncogene
. 2012
;31
:3190
–201
. .47.
Hu
X
, Harvey
SE
, Zheng
R
, Lyu
J
, Grzeskowiak
CL
, Powell
E
, The RNA-binding protein AKAP8 suppresses tumor metastasis by antagonizing EMT-associated alternative splicing
. Nat Commun
. 2020
;11
:486
. .48.
Hua
Y
, Sahashi
K
, Hung
G
, Rigo
F
, Passini
MA
, Bennett
CF
, Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
. Genes Dev
. 2010
;24
:1634
–44
. .49.
Huang
H
, Zhang
J
, Harvey
SE
, Hu
X
, Cheng
C
. RNA G-quadruplex secondary structure promotes alternative splicing via the RNA-binding protein hnRNPF
. Genes Dev
. 2017
;31
:2296
–309
. .50.
Ishii
H
, Saitoh
M
, Sakamoto
K
, Kondo
T
, Katoh
R
, Tanaka
S
, Epithelial splicing regulatory proteins 1 (ESRP1) and 2 (ESRP2) suppress cancer cell motility via different mechanisms
. J Biol Chem
. 2014
;289
:27386
–99
. .51.
Ishiyama
N
, Lee
SH
, Liu
S
, Li
GY
, Smith
MJ
, Reichardt
LF
, Dynamic and static interactions between p120 catenin and E-cadherin regulate the stability of cell-cell adhesion
. Cell
. 2010
;141
:117
–28
. .52.
Jeck
WR
, Sharpless
NE
. Detecting and characterizing circular RNAs
. Nat Biotechnol
. 2014
;32
:453
–61
. .53.
Kalluri
R
, Weinberg
RA
. The basics of epithelial-mesenchymal transition
. J Clin Invest
. 2009
;119
:1420
–8
. .54.
Kasimir-Bauer
S
, Hoffmann
O
, Wallwiener
D
, Kimmig
R
, Fehm
T
. Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells
. Breast Cancer Res
. 2012
;14
:R15
. .55.
Kelemen
O
, Convertini
P
, Zhang
Z
, Wen
Y
, Shen
M
, Falaleeva
M
, Function of alternative splicing
. Gene
. 2013
;514
:1
–30
. .56.
Keren
H
, Lev-Maor
G
, Ast
G
. Alternative splicing and evolution: diversification, exon definition and function
. Nat Rev Genet
. 2010
;11
:345
–55
. .57.
Kim
DH
, Xing
T
, Yang
Z
, Dudek
R
, Lu
Q
, Chen
YH
. Epithelial mesenchymal transition in embryonic development, tissue repair and cancer: a comprehensive overview
. J Clin Med
. 2017
;7
(1
):1
. .58.
Kim
YE
, Won
M
, Lee
SG
, Park
C
, Song
CH
, Kim
KK
. RBM47-regulated alternative splicing of TJP1 promotes actin stress fiber assembly during epithelial-to-mesenchymal transition
. Oncogene
. 2019
;38
:6521
–36
. .59.
Kristensen
LS
, Andersen
MS
, Stagsted
LVW
, Ebbesen
KK
, Hansen
TB
, Kjems
J
. The biogenesis, biology and characterization of circular RNAs
. Nat Rev Genet
. 2019
;20
:675
–91
. .60.
Kung
JT
, Colognori
D
, Lee
JT
. Long noncoding RNAs: past, present, and future
. Genetics
. 2013
;193
:651
–69
. .61.
Lamouille
S
, Xu
J
, Derynck
R
. Molecular mechanisms of epithelial-mesenchymal transition
. Nat Rev Mol Cell Biol
. 2014
;15
:178
–96
. .62.
Lapuk
A
, Marr
H
, Jakkula
L
, Pedro
H
, Bhattacharya
S
, Purdom
E
, Exon-level microarray analyses identify alternative splicing programs in breast cancer
. Mol Cancer Res
. 2010
;8
:961
–74
. .63.
Lau
WM
, Teng
E
, Chong
HS
, Lopez
KA
, Tay
AY
, Salto-Tellez
M
, CD44v8-10 is a cancer-specific marker for gastric cancer stem cells
. Cancer Res
. 2014
;74
:2630
–41
. .64.
Lecharpentier
A
, Vielh
P
, Perez-Moreno
P
, Planchard
D
, Soria
JC
, Farace
F
. Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer
. Br J Cancer
. 2011
;105
:1338
–41
. .65.
Lee
JY
, Kong
G
. Roles and epigenetic regulation of epithelial-mesenchymal transition and its transcription factors in cancer initiation and progression
. Cell Mol Life Sci
. 2016
;73
:4643
–60
. .66.
Lee
S
, Cieply
B
, Yang
Y
, Peart
N
, Glaser
C
, Chan
P
, Esrp1-regulated splicing of Arhgef11 isoforms is required for epithelial tight junction integrity
. Cell Rep
. 2018
;25
:2417
–e5
. .67.
Lee
S
, Sears
MJ
, Zhang
Z
, Li
H
, Salhab
I
, Krebs
P
, Cleft lip and cleft palate in Esrp1 knockout mice is associated with alterations in epithelial-mesenchymal crosstalk
. Development
. 2020
;147
(21
):dev187369
. .68.
Li
J
, Choi
PS
, Chaffer
CL
, Labella
K
, Hwang
JH
, Giacomelli
AO
, An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer
. eLife
. 2018
;7
:e37184
. .69.
Liu
S
, Cheng
C
. Alternative RNA splicing and cancer
. Wiley Interdiscip Rev RNA
. 2013
;4
:547
–66
. .70.
Liu
S
, Cheng
C
. Akt signaling is sustained by a CD44 splice isoform-mediated positive feedback loop
. Cancer Res
. 2017
;77
:3791
–801
. .71.
Lu
H
, Liu
J
, Liu
S
, Zeng
J
, Ding
D
, Carstens
RP
, Exo70 isoform switching upon epithelial-mesenchymal transition mediates cancer cell invasion
. Dev Cell
. 2013
;27
:560
–73
. .72.
Magen
A
, Ast
G
. The importance of being divisible by three in alternative splicing
. Nucleic Acids Res
. 2005
;33
:5574
–82
. .73.
Marchese
FP
, Raimondi
I
, Huarte
M
. The multidimensional mechanisms of long noncoding RNA function
. Genome Biol
. 2017
;18
:206
. .74.
Matos
P
, Jordan
P
. Expression of Rac1b stimulates NF-kappaB-mediated cell survival and G1/S progression
. Exp Cell Res
. 2005
;305
:292
–9
. .75.
Matter
N
, Herrlich
P
, König
H
. Signal-dependent regulation of splicing via phosphorylation of Sam68
. Nature
. 2002
;420
:691
–5
. .76.
Mima
K
, Okabe
H
, Ishimoto
T
, Hayashi
H
, Nakagawa
S
, Kuroki
H
, CD44s regulates the TGF-β-mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma
. Cancer Res
. 2012
;72
:3414
–23
. .77.
Miyake
K
, Underhill
CB
, Lesley
J
, Kincade
PW
. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition
. J Exp Med
. 1990
;172
:69
–75
. .78.
Modugno
FD
, Iapicca
P
, Boudreau
A
, Mottolese
M
, Terrenato
I
, Perracchio
L
, Splicing program of human MENA produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumors
. PNAS
. 2012
;109
:19280
–5
.79.
Moerlooze
LD
, Spencer-Dene
B
, Revest
J
, Hajihosseini
M
, Rosewell
I
, Dickson
C
. An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis
. Development
. 2000
;127
:483
–92
.80.
Morel
AP
, Hinkal
GW
, Thomas
C
, Fauvet
F
, Courtois-Cox
S
, Wierinckx
A
, EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice
. PLoS Genet
. 2012
;8
:e1002723
. .81.
Nakajima
Y
, Yamagishi
T
, Hokari
S
, Nakamura
H
. Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: roles of transforming growth factor (TGF)-β and bone morphogenetic protein (BMP)
. Anat Rec
. 2000
;258
:119
–27
.82.
Nieto
MA
. Epithelial plasticity: a common theme in embryonic and cancer cells
. Science
. 2013
;342
(6159
):1234850
. .83.
Nieto
MA
. Context-specific roles of EMT programmes in cancer cell dissemination
. Nat Cell Biol
. 2017
;19
:416
–8
. .84.
Nieto
MA
, Huang
RY
, Jackson
RA
, Thiery
JP
. EMT: 2016
. Cell
. 2016
;166
:21
–45
. .85.
Orr-Urtreger
A
, Bedford
MT
, Burakova
T
, Arman
E
, Zimmer
Y
, Yayon
A
, Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2)
. Dev Biol
. 1993
;158
:475
–86
. .86.
Ouhtit
A
, Abd Elmageed
ZY
, Abdraboh
ME
, Lioe
TF
, Raj
MH
. In vivo evidence for the role of CD44s in promoting breast cancer metastasis to the liver
. Am J Pathol
. 2007
;171
:2033
–9
. .87.
Pan
Q
, Shai
O
, Lee
LJ
, Frey
BJ
, Blencowe
BJ
. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing
. Nat Genet
. 2008
;40
:1413
–5
. .88.
Park
NR
, Cha
JH
, Jang
JW
, Bae
SH
, Jang
B
, Kim
JH
, Synergistic effects of CD44 and TGF-β1 through AKT/GSK-3β/β-catenin signaling during epithelial-mesenchymal transition in liver cancer cells
. Biochem Biophys Res Commun
. 2016
;477
:568
–74
. .89.
Pastushenko
I
, Blanpain
C
. EMT transition states during tumor progression and metastasis
. Trends Cell Biol
. 2019
;29
:212
–26
. .90.
Peinado
H
, Olmeda
D
, Cano
A
. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
Nat Rev Cancer
. 2007
;7
:415
–28
. .91.
Pérez-Pomares
JM
, Muñoz-Chápuli
R
. Epithelial-mesenchymal transitions: a mesodermal cell strategy for evolutive innovation in Metazoans
. Anat Rec
. 2002
;268
:343
–51
. .92.
Pillman
KA
, Phillips
CA
, Roslan
S
, Toubia
J
, Dredge
BK
, Bert
AG
, miR-200/375 control epithelial plasticity-associated alternative splicing by repressing the RNA-binding protein Quaking
. EMBO J
. 2018
;37
(13
):e99016
. .93.
Polyak
K
, Weinberg
RA
. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
. Nat Rev Cancer
. 2009
;9
:265
–73
. .94.
Ponta
H
, Sherman
L
, Herrlich
PA
. CD44: from adhesion molecules to signalling regulators
. Nat Rev Mol Cell Biol
. 2003
;4
:33
–45
. .95.
Pradella
D
, Naro
C
, Sette
C
, Ghigna
C
. EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression
. Mol Cancer
. 2017
;16
:8
. .96.
Preca
BT
, Bajdak
K
, Mock
K
, Sundararajan
V
, Pfannstiel
J
, Maurer
J
, A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells
. Int J Cancer
. 2015
;137
:2566
–77
. .97.
Qiu
Y
, Lyu
J
, Dunlap
M
, Harvey
SE
, Cheng
C
. A combinatorially regulated RNA splicing signature predicts breast cancer EMT states and patient survival
. RNA
. 2020
;26
(9
):1257
–67
.98.
Radisky
DC
, Levy
DD
, Littlepage
LE
, Liu
H
, Nelson
CM
, Fata
JE
, Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability
. Nature
. 2005
;436
:123
–7
. .99.
Reinke
LM
, Xu
Y
, Cheng
C
. Snail represses the splicing regulator epithelial splicing regulatory protein 1 to promote epithelial-mesenchymal transition
. J Biol Chem
. 2012
;287
(43
):36435
–42
. .100.
Roca
H
, Hernandez
J
, Weidner
S
, McEachin
RC
, Fuller
D
, Sud
S
, Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer
. PLoS One
. 2013
;8
:e76773
. .101.
Rohacek
AM
, Bebee
TW
, Tilton
RK
, Radens
CM
, McDermott-Roe
C
, Peart
N
, ESRP1 mutations cause hearing loss due to defects in alternative splicing that disrupt cochlear development
. Dev Cell
. 2017
;43
:318
–e5
. .102.
Romero
PR
, Zaidi
S
, Fang
YY
, Uversky
VN
, Radivojac
P
, Oldfield
CJ
, Alternative splicing in concert with protein intrinsic disorder enables increased functional diversity in multicellular organisms
. Proc Natl Acad Sci U S A
. 2006
;103
:8390
–5
. .103.
Sandberg
R
, Neilson
JR
, Sarma
A
, Sharp
PA
, Burge
CB
. Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites
. Science
. 2008
;320
:1643
–7
. .104.
Savagner
P
, Vallés
AM
, Jouanneau
J
, Yamada
KM
, Thiery
JP
. Alternative splicing in fibroblast growth factor receptor 2 is associated with induced epithelial-mesenchymal transition in rat bladder carcinoma cells
. Mol Biol Cell
. 1994
;5
:851
–62
. .105.
Schnelzer
A
, Prechtel
D
, Knaus
U
, Dehne
K
, Gerhard
M
, Graeff
H
, Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b
. Oncogene
. 2000
;19
:3013
–20
. .106.
Shapiro
IM
, Cheng
AW
, Flytzanis
NC
, Balsamo
M
, Condeelis
JS
, Oktay
MH
, An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype
. PLoS Genet
. 2011
;7
:e1002218
. .107.
Shi
Y
. Mechanistic insights into precursor messenger RNA splicing by the spliceosome
. Nat Rev Mol Cell Biol
. 2017
;18
:655
–70
. .108.
Shirakihara
T
, Horiguchi
K
, Miyazawa
K
, Ehata
S
, Shibata
T
, Morita
I
, TGF-β regulates isoform switching of FGF receptors and epithelial-mesenchymal transition
. EMBO J
. 2011
;30
:783
–95
. .109.
Singh
A
, Karnoub
AE
, Palmby
TR
, Lengyel
E
, Sondek
J
, Der
CJ
. Rac1b, a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation
. Oncogene
. 2004
;23
:9369
–80
. .110.
Slorach
EM
, Chou
J
, Werb
Z
. Zeppo1 is a novel metastasis promoter that represses E-cadherin expression and regulates p120-catenin isoform expression and localization
. Genes Dev
. 2011
;25
:471
–84
. .111.
Thiery
JP
. Epithelial-mesenchymal transitions in development and pathologies
. Curr Opin Cell Biol
. 2003
;15
:740
–6
. .112.
Thiery
JP
, Acloque
H
, Huang
RY
, Nieto
MA
. Epithelial-mesenchymal transitions in development and disease
. Cell
. 2009
;139
:871
–90
. .113.
Thiery
JP
, Sleeman
JP
. Complex networks orchestrate epithelial-mesenchymal transitions
. Nat Rev Mol Cell Biol
. 2006
;7
:131
–42
. .114.
Todaro
M
, Gaggianesi
M
, Catalano
V
, Benfante
A
, Iovino
F
, Biffoni
M
, CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis
. Cell Stem Cell
. 2014
;14
:342
–56
. .115.
Tripathi
V
, Shin
JH
, Stuelten
CH
, Zhang
YE
. TGF-β-induced alternative splicing of TAK1 promotes EMT and drug resistance
. Oncogene
. 2019
;38
:3185
–200
. .116.
Tripathi
V
, Sixt
KM
, Gao
S
, Xu
X
, Huang
J
, Weigert
R
, Direct regulation of alternative splicing by SMAD3 through PCBP1 Is essential to the tumor-promoting role of TGF-β
. Mol Cell
. 2016
;64
:549
–64
. .117.
Tsai
JH
, Yang
J
. Epithelial-mesenchymal plasticity in carcinoma metastasis
. Genes Dev
. 2013
;27
:2192
–206
. .118.
Underwood
JG
, Boutz
PL
, Dougherty
JD
, Stoilov
P
, Black
DL
. Homologues of the Caenorhabditis elegans Fox-1 protein are neuronal splicing regulators in mammals
. Mol Cell Biol
. 2005
;25
:10005
–16
. .119.
Valacca
C
, Bonomi
S
, Buratti
E
, Pedrotti
S
, Baralle
FE
, Sette
C
, Sam68 regulates EMT through alternative splicing-activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene
. J Cell Biol
. 2010
;191
:87
–99
. .120.
Vanharanta
S
, Marney
CB
, Shu
W
, Valiente
M
, Zou
Y
, Mele
A
, Loss of the multifunctional RNA-binding protein RBM47 as a source of selectable metastatic traits in breast cancer
. Elife
. 2014
;3
:e02734
. .121.
Venables
JP
, Brosseau
JP
, Gadea
G
, Klinck
R
, Prinos
P
, Beaulieu
JF
, RBFOX2 is an important regulator of mesenchymal tissue-specific splicing in both normal and cancer tissues
. Mol Cell Biol
. 2013
;33
:396
–405
. .122.
Wahl
MC
, Will
CL
, Lührmann
R
. The spliceosome: design principles of a dynamic RNP machine
. Cell
. 2009
;136
:701
–18
. .123.
Wang
ET
, Sandberg
R
, Luo
S
, Khrebtukova
I
, Zhang
L
, Mayr
C
, Alternative isoform regulation in human tissue transcriptomes
. Nature
. 2008
;456
:470
–6
. .124.
Warzecha
CC
, Jiang
P
, Amirikian
K
, Dittmar
KA
, Lu
H
, Shen
S
, An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition
. EMBO J
. 2010
;29
:3286
–300
. .125.
Warzecha
CC
, Sato
TK
, Nabet
B
, Hogenesch
JB
, Carstens
RP
. ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing
. Mol Cell
. 2009
;33
:591
–601
. .126.
Weise
A
, Bruser
K
, Elfert
S
, Wallmen
B
, Wittel
Y
, Wöhrle
S
, Alternative splicing of Tcf7l2 transcripts generates protein variants with differential promoter-binding and transcriptional activation properties at Wnt/beta-catenin targets
. Nucleic Acids Res
. 2010
;38
:1964
–81
. .127.
Wellner
U
, Schubert
J
, Burk
UC
, Schmalhofer
O
, Zhu
F
, Sonntag
A
, The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
. Nat Cell Biol
. 2009
;11
:1487
–95
. .128.
Xing
Y
, Lee
CJ
. Protein modularity of alternatively spliced exons is associated with tissue-specific regulation of alternative splicing
. PLoS Genet
. 2005
;1
:e34
. .129.
Xu
Y
, Gao
XD
, Lee
JH
, Huang
H
, Tan
H
, Ahn
J
, Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative splicing
. Genes Dev
. 2014
;28
:1191
–203
. .130.
Yanagisawa
M
, Huveldt
D
, Kreinest
P
, Lohse
CM
, Cheville
JC
, Parker
AS
, A p120 catenin isoform switch affects Rho activity, induces tumor cell invasion, and predicts metastatic disease
. J Biol Chem
. 2008
;283
:18344
–54
. .131.
Yang
Y
, Carstens
RP
. Alternative splicing regulates distinct subcellular localization of Epithelial splicing regulatory protein 1 (Esrp1) isoforms
. Sci Rep
. 2017
;7
:3848
–10
. .132.
Yang
Y
, Park
JW
, Bebee
TW
, Warzecha
CC
, Guo
Y
, Shang
X
, Determination of a comprehensive alternative splicing regulatory network and combinatorial regulation by key factors during the epithelial-to-mesenchymal transition
. Mol Cell Biol
. 2016
;36
:1704
–19
. .133.
Ye
X
, Brabletz
T
, Kang
Y
, Longmore
GD
, Nieto
MA
, Stanger
BZ
, Upholding a role for EMT in breast cancer metastasis
. Nature
. 2017
;547
:E1
–3
. .134.
Yeh
BK
, Igarashi
M
, Eliseenkova
AV
, Plotnikov
AN
, Sher
I
, Ron
D
, Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors
. Proc Natl Acad Sci U S A
. 2003
;100
:2266
–71
. .135.
Yeo
GW
, Coufal
NG
, Liang
TY
, Peng
GE
, Fu
XD
, Gage
FH
. An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells
. Nat Struct Mol Biol
. 2009
;16
:130
–7
. .136.
Yeung
KT
, Yang
J
. Epithelial-mesenchymal transition in tumor metastasis
. Mol Oncol
. 2017
;11
:28
–39
. .137.
Yoshikawa
M
, Tsuchihashi
K
, Ishimoto
T
, Yae
T
, Motohara
T
, Sugihara
E
, xCT inhibition depletes CD44v-expressing tumor cells that are resistant to EGFR-targeted therapy in head and neck squamous cell carcinoma
. Cancer Res
. 2013
;73
:1855
–66
. .138.
Yu
L
, Zhang
H
, Guan
X
, Qin
D
, Zhou
J
, Wu
X
. Loss of ESRP1 blocks mouse oocyte development and leads to female infertility
. Development
. 2021
:148
(2
):196931
.139.
Yu
M
, Bardia
A
, Wittner
BS
, Stott
SL
, Smas
ME
, Ting
DT
, Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition
. Science
. 2013
;339
(6119
):580
–4
. .140.
Zeilstra
J
, Joosten
SP
, van Andel
H
, Tolg
C
, Berns
A
, Snoek
M
, Stem cell CD44v isoforms promote intestinal cancer formation in Apc(min) mice downstream of Wnt signaling
. Oncogene
. 2014
;33
:665
–70
. .141.
Zhang
C
, Zhang
Z
, Castle
J
, Sun
S
, Johnson
J
, Krainer
AR
, Defining the regulatory network of the tissue-specific splicing factors Fox-1 and Fox-2
. Genes Dev
. 2008
;22
:2550
–63
. .142.
Zhang
H
, Brown
RL
, Wei
Y
, Zhao
P
, Liu
S
, Liu
X
, CD44 splice isoform switching determines breast cancer stem cell state
. Genes Dev
. 2019a
;33
:166
–79
. .143.
Zhang
J
, Harvey
SE
, Cheng
C
. A high-throughput screen identifies small molecule modulators of alternative splicing by targeting RNA G-quadruplexes
. Nucleic Acids Res
. 2019b
;47
:3667
–79
. .144.
Zhang
X
, Ibrahimi
OA
, Olsen
SK
, Umemori
H
, Mohammadi
M
, Ornitz
DM
. Receptor specificity of the fibroblast growth factor family: the complete mammalian FGF family
. J Biol Chem
. 2006
;281
:15694
–700
.145.
Zhao
P
, Xu
Y
, Wei
Y
, Qiu
Q
, Chew
TL
, Kang
Y
, The CD44s splice isoform is a central mediator for invadopodia activity
. J Cell Sci
. 2016
;129
:1355
–65
. .146.
Zhao
Q
, Caballero
OL
, Davis
ID
, Jonasch
E
, Tamboli
P
, Yung
WK
, Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas
. Clin Cancer Res
. 2013
;19
:2460
–72
. .147.
Zheng
X
, Carstens
JL
, Kim
J
, Scheible
M
, Kaye
J
, Sugimoto
H
, Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
. Nature
. 2015
;527
:525
–30
. .148.
Zhou
YQ
, He
C
, Chen
YQ
, Wang
D
, Wang
MH
. Altered expression of the RON receptor tyrosine kinase in primary human colorectal adenocarcinomas: generation of different splicing RON variants and their oncogenic potential
. Oncogene
. 2003
;22
:186
–97
. .© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
